21:05:31 EDT Wed 18 Jun 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

T:SVA - SERNOVA BIOTHERAPEUTICS INC - https://www.sernova.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
SVA - T  2.00.16·0.16525.00.16548.1780.16  0.165  0.160.39  0.1511:32:37Jun 1615 min RT 2¢
TSX - T2.00.16·0.16525.00.165    0.39  0.15Jun 1715 min
Alpha - A 0.16-0.005-3.045.5730.16  0.16  0.1610:55:3315 min
Omega - O 0.1652.0020.165  0.165  0.16511:32:3715 min
CX2 - H 0.1650.31    Jun 1715 min
CXD - D 0.1650.31    May 2715 min
TriAct - M 0.1650.0031    Sep 10-2015 min

Recent Trades - All 8 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
12:41:10M0.16-0.005380 National Bank80 National BankE
11:32:37O0.165 1,00085 Scotia1 AnonymousK
11:31:16O0.165 1,00085 Scotia1 AnonymousK
10:55:33H0.16-0.00532680 National Bank13 InstinetE
10:55:33A0.16-0.00510,5001 Anonymous13 InstinetK
10:55:33A0.16-0.00515,00079 CIBC13 InstinetK
10:55:31A0.16-0.00520,0001 Anonymous13 InstinetK
09:39:04D0.165 3037 TD Sec7 TD SecE
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-06-16 19:41C:SVA0.16Street WireSernova ex Haghighat pleads not guilty
2025-06-13 16:30C:SVA0.165SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-06-13 16:30C:SVA0.165SEDAR Interim MD & ASEDAR Interim MD & A
2025-06-02 20:26C:SVA0.17News ReleaseSernova appoints Rigby as interim chair
2025-05-26 02:26C:SVA0.195News ReleaseSernova chair Haghighat resigns
2025-05-23 19:00C:SVA0.195Street WireSernova's Haghighat charged for insider trading
2025-05-22 14:58C:SVA0.22News ReleaseSernova Biotherapeutics forms clinical advisory board
2025-05-14 15:52C:SVA0.21News ReleaseSernova talks interim data from Cell Pouch trial
2025-04-17 17:09C:SVA0.20News ReleaseSernova closes $4-million term loan from Navigate
2025-04-15 18:48C:SVA0.18News ReleaseSernova to highlight Cell Pouch organ at Rome meeting
2025-04-01 17:17C:SVA0.165News ReleaseSernova to continue to Cohort C T1D trial in H2 2025
2025-03-14 16:03C:SVA0.175SEDAR Interim MD & ASEDAR Interim MD & A
2025-03-14 15:58C:SVA0.175SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-03-10 17:13C:SVA0.185News ReleaseSernova appoints Calias as CDO, R&D head
2025-03-05 12:32C:SVA0.19News ReleaseSernova arranges $1-million debenture financing
2025-03-03 19:48C:SVA0.20News ReleaseSernova receives FDA clearance for IND application
2025-02-07 18:04C:SVA0.21Change NameSernova name change to Sernova Biotherapeutics
2025-02-03 18:58C:SVA0.205News ReleaseSernova applies for investigational new drug to FDA
2025-01-30 16:44C:SVA0.21News ReleaseSernova appoints Haghighat as chair
2025-01-13 11:37C:SVA0.225News ReleaseSernova shareholders elect six directors at ASM